Genes and cholangiocarcinoma

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 40, Issue 4, 2009, Pages 701-712

  Sawanyawisuth, Kanlayanee ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

BILE DUCT CARCINOMA; CLONORCHIASIS; GENE EXPRESSION PROFILING; GENETICS; HUMAN; METASTASIS; OPISTHORCHIASIS; PARASITOLOGY; PATHOLOGY; PROGNOSIS; REVIEW; RISK FACTOR;

CHOLANGIOCARCINOMA; CLONORCHIASIS; GENE EXPRESSION PROFILING; HUMANS; NEOPLASM METASTASIS; OPISTHORCHIASIS; PROGNOSIS; RISK FACTORS;

EID: 68649112148     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Review

References (66)

1. Aishima SI, Taguchi KI, Sugimachi K, Shimada M, Tsuneyoshi M. c-erbB-2 and c-Met expression relates to cholangiocarcinogenesis and progression of intrahepatic cholangio-carcinoma. Histopathology 2002; 40: 269-78.
2. Anderson CD, Pinson CW, Berlin J, Chari RS. Diagnosis and treatment of cholangiocarcinoma. Oncologist 2004; 9: 43-57.
3. Bartsch H, Ohshima H, Pignatelli B, Calmels S. Endogenously formed N-nitroso compounds and nitrosating agents in human cancer etiology. Pharmacogenetics 1992; 2: 272-7.
4. Basak S, Jacobs SB, Krieg AJ, et al. The metastasis-associated gene Prl-3 is a p53 target involved in cell-cycle regulation. Mol Cell 2008; 30: 303-14.
5. Carriage MT, Henson DE. Liver, gallbladder, ex-trahepatic bile ducts, and pancreas. Cancer 1995; 75:171-90.
6. Catalano A, Romano M, Robuffo I, Strizzi L, Procopio A. Methionine aminopeptidase-2 regulates human mesothelioma cell survival: role of Bcl-2 expression and telomerase activity. Am J Pathol 2001; 159: 721-31.
7. Chinnasri P, Pairojkul C, Jearanaikoon P, et al. Preferentially different mechanisms of inac-tivation of 9p21 gene cluster in liver fluke-related cholangiocarcinoma. Hum Pathol 2009 [Epub ahead of print].
8. Datta B, Datta R. Induction of apoptosis due to lowering the level of eukaryotic initiation factor 2-associated protein, p67, from mammalian cells by antisense approach. Exp Cell Res 1999; 246: 376-83.
9. Farley DR, Weaver AL, Nagorney DM. "Natural history" of unresected cholangiocarcinoma: patient outcome after noncurative intervention. Mayo Clin Proc 1995; 70: 425-9.
10. Gores GJ. Cholangiocarcinoma: current concepts and insights. Hepatology 2003; 37: 961-9.
11. Hanazaki K, Kajikawa S, Shimozawa N, et al. Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis. Hepatogastroenteroiogy 2002; 49: 311-6.
12. Hansel DE, Rahman A, Hidalgo M, et al. Identification of novel cellular targets in biliary tract cancers using global gene expression technology. Am J Pathol 2003; 163: 217-29.
13. Hirohashi K, Uenishi T, Kubo S, et al. Macroscopic types of intrahepatic cholangiocarcinoma: clinicopathologic features and surgical outcomes. Hepatogastroenterology 2002; 49: 326-9.
14. Hou PC. The relationship between primary carcinoma of the liver and infestation with clonorchiasis sinensis. J Path Bact 1956; 72: 239-46.
15. Ito Y, Takeda T, Sasaki Y, et al. Bcl-2 expression in cholangiocellular carcinoma is inversely correlated with biologically aggressive phe-notypes. Oncology 2000; 59: 63-7.
16. Ito Y, Takeda T, Sasaki Y, et al. Expression and clinical significance of the G1-S modulators in intrahepatic cholangiocellular carcinoma. Oncology 2001; 60: 242-51.
17. Junking M, Wongkham C, Sripa B, Sawanya-wisuth K, Araki N, Wongkham S. Decreased expression of galectin-3 is associated with metastatic potential of liver fluke-associated cholangiocarcinoma. Eur J Cancer 2008; 44: 619-26.
18. Juntavee A, Sripa B, Pugkhem A, Khuntikeo N, Wongkham S. Expression of sialyl Lewis(a) relates to poor prognosis in cholangiocarcinoma. World ] Gastroenterol 2005; 11:249-54.
19. Khan SA, Taylor-Robinson SD, Toledano MB, Beck A, Elliott P, Thomas HC. Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J Hepatol 2002; 37: 806-13.
20. Khan SA, Toledano MB, Taylor-Robinson SD. Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma. HPB (Oxford) 2008; 10: 77-82.
21. Khuntikeo N, Pugkhem A, Bhudhisawasdi V, Uttaravichien T. Major hepatic resection for hilar cholangiocarcinoma without preoperative biliary drainage. Asian Pac J Cancer Prev 2008; 9: 83-5.
22. Lee YM, Kaplan MM. Primary sclerosing cholangitis. N Engl J Med 1995; 332: 924-33.
23. Leelawat K, Leelawat S, Narong S, Hongeng S. Roles of the MEK1/2 and AKT pathways in CXCL 12/CXCR4 induced cholangiocarcinoma cell invasion. World J Gastroenterol 2007; 13:1561-8.
24. Leelawat K, Narong S, Udomchaiprasertkul W, Leelawat S, Tungpradubkul S. Inhibition of PI3K increases oxaliplatin sensitivity in cholangiocarcinoma cells. Cancer Cell Int 2009; 9: 3.
25. Limpaiboon T, Khaenam P, Chinnasri P, et al. Promoter hypermethylation is a major event of MLH1 gene inactivation in liver fluke related cholangiocarcinoma. Cancer Lett 2005; 217: 213-9.
26. Limpaiboon T, Tapdara S, Jearanaikoon P, Sripa B, Bhudhisawasdi V. Prognostic significance of microsatellite alterations at lp36 in cholangiocarcinoma. World } Gastroenterol 2006; 12: 4377-82.
27. Liu D, Momoi H, Li L, Ishikawa Y, Fukumoto M. Microsatellite instability in thorotrast-in-duced human intrahepatic cholangiocarcinoma. Int J Cancer 2002; 102: 366-71.
28. Maeda T, Sepe P, Lahousse S, el al. Antisense oligodeoxynucleotides directed against as-partyl (asparaginyl) beta-hydroxylase suppress migration of cholangiocarcinoma cells. J Hepatol 2003; 38: 615-22.
29. Mitacek EJ, Brunnemann KD, Hoffmann D, et al. Volatile nitrosamines and tobacco-specific nitrosamines in the smoke of Thai cigarettes: a risk factor for lung cancer and a suspected risk factor for liver cancer in Thailand. Carcinogenesis 1999; 20: 133-7.
30. Muenphon K, Limpaiboon T, Jearanaikoon P, Pairojkul C, Sripa B, Bhudhisawasdi V. Amplification of chromosome 21q22.3 harboring trefoil factor family genes in liver fluke related cholangiocarcinoma is associated with poor prognosis. World J Gastroenterol 2006; 12: 4143-8.
31. Nakeeb A, Pitt HA, Sohn TA, et al. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 1996; 224: 463-73.
32. Namieno T, Koito K, Takahashi M, Une Y, Yamashita K, Shimamura T. Survival-associated histologic spreading modes of operable intrahepatic, peripheral-type cholan-giocarcinomas. World] Surg 2001; 25: 572-7.
33. Obama K, Ura K, Li M, et al. Genome-wide analysis of gene expression in human intrahepatic cholangiocarcinoma. Hepatology 2005; 41: 1339-48.
34. Ohshima H, Bandaletova TY, Brouet I, et al. Increased nitrosamine and nitrate biosynthesis mediated by nitric oxide synthase induced in hamsters infected with liver fluke (Opisthorchis viverrini). Carcinogenesis 1994; 15: 271-5.
35. Okabayashi T, Yamamoto J, Kosuge T, et al. A new staging system for mass-forming intrahepatic cholangiocarcinoma: analysis of preoperative and postoperative variables. Cancer 2001; 92: 2374-83.
36. Pairojkul C, Shirai T, Hirohashi S, et al. Multistage carcinogenesis of liver-fluke-associated cholangiocarcinoma in Thailand. Princess Takamatsu Symp 1991; 22: 77-86.
37. Parkin DM, Ohshima H, Srivatanakul P, Vatanasapt V. Cholangiocarcinoma: epidemiology, mechanisms of carcinogenesis and prevention. Cancer Epidemiol Biomarkers Preυ 1993; 2: 537-44.
38. Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 2001; 33:1353-7.
39. Pinlaor S, Ma N, Hiraku Y, et al. Repeated infection with Opisthorchis viverrini induces accumulation of 8-nitroguanine and 8-oxo-7, 8-dihydro-2'-deoxyguanine in the bile duct of hamsters via inducible nitric oxide synthase. Carcinogenesis 2004; 25:1535-42.
40. Pinlaor S, Yongvanit P, Hiraku Y, et al. 8-nitroguanine formation in the liver of hamsters infected with Opisthorchis viverrini. Biochem Biophys Res Commun 2003; 309:567-71.
41. Rosen CB, Nagorney DM, Wiesner RH, Coffey RJ Jr, LaRusso NF. Cholangiocarcinoma complicating primary sclerosing cholangitis. Ann Surg 1991; 213: 21-5.
42. Reyes I, Tiwari R, Geliebter J, Reyes N. DNA microarray analysis reveals metastasis-associated genes in rat prostate cancer cell lines. Biomedica 2007; 27:190-203.
43. Satarug S, Haswell-Elkins MR, Tsuda M, et al. Thiocyanate- independent nitrosation in humans with carcinogenic parasite infection. Carcinogenesis 1996; 17:1075-81.
44. Sawanyawisuth K, Wongkham C, Pairojkul C, el al. Methionine aminopeptidase 2 over-expressed in cholangiocarcinoma: potential for drug target. Acta Oncol 2007; 46: 378-85.
45. Selvakumar P, Lakshmikuttyamma A, Dimmock JR, Sharma RK. Methionine aminopeptidase 2 and cancer. Biochim Biophys Acta 2006; 1765:148-54.
46. Shirabe K, Shimada M, Harimoto N, el al. Intrahepatic cholangiocarcinoma: its mode of spreading and therapeutic modalities. Surgery 2002; 131: S159'-64.
47. Shirabe K, Shimada M, Kajiyama K, el al. Expression of matrix metalloproteinase-9 in surgically resected intrahepatic cholangiocarcinoma. Surgery 1999; 126: 842-6.
48. Sriamporn S, Pisani P, Pipitgool V, Suwan-rungruang K, Kamsa-ard S, Parkin DM. Prevalence of Opisthorchis viverrini infection and incidence of cholangiocarcinoma in Khon Kaen, Northeast Thailand. Trop Med Int Health 2004; 9: 588-94.
49. Sripa B, Kaewkes S, Sithithaworn P, et al. Liver fluke induces cholangiocarcinoma. PLos Med 2007; 4: e201.
50. Sripa B, Pairojkul C. Pathology of cholangiocarcinoma. In: Vatanasapt V, Sripa B, eds. Liver cancer in Thailand; epidemiology, diagnosis and control. Khon Kaen: Siriphan Press 2000: 65-100.
51. Sripa B, Pairojkul C. Cholangiocarcinoma: lessons from Thailand. Curr Opin Gastroenterol 2008; 24: 349-56.
52. Srisomsap C, Subhasitanont P, Sawangareetrakul P, et al. Comparison of membrane-associated proteins in human cholangiocarcinoma and hepatocellular carcinoma cell lines. Proteomics Clin Appl 2007; 1: 89-106.
53. Srivatanakul P, Ohshima H, Khlat M, et al. Endogenous nitrosamines and liver fluke as risk factors for cholangiocarcinoma in Thailand. IARC Sci Publ 1991; 105: 88-95.
54. Stein U, Walther W, Arlt F, et al. M ACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis. Nat Med 2009; 15: 59-67.
55. Suzuki S, Sakaguchi T, Yokoi Y, et al. Clinico-pathological prognostic factors and impact of surgical treatment of mass-forming intrahepatic cholangiocarcinoma. World J Surg 2002; 26: 687-93.
56. Tanaka S, Sugimachi K, Kameyama T, et al. Human WISPlv, a member of the CCN family, is associated with invasive cholangiocarcinoma. Hepatology 2003; 37:1122-9.
57. Taoka H, Kawarada Y. Intrahepatic bile duct carcinoma (cholangiocarcinoma). Nippon Geka Gakkai Zasshi 1997; 98: 484-90.
58. Thamavit W, Pairojkul C, Tiwawech D, Itoh M, Shirai T, Ito N. Promotion of cholangiocarci-nogenesis in the hamster liver by bile duct ligation after dimethylnitrosamine initiation. Carcinogenesis 1993; 14: 2415-7.
59. Thamavit W, Pairojkul C, Tiwawech D, Shirai T, Ito N. Strong promoting effect of Opisthorchis viverrini infection on dimeth-ylnitrosamine- initiated hamster liver. Cancer Lett 1994; 78:121-5.
60. Thanasai J, Limpaiboon T, Jearanaikoon P, et al. Amplification of D22S283 as a favorable prognostic indicator in liver fluke related cholangiocarcinoma. World J Gastroenterol 2006; 12: 4338-44.
61. Thuwajit C, Thuwajit P, Kaewkes S, et al. Increased cell proliferation of mouse fibroblast NIH-3T3 in vitro induced by excretory/secretory product(s) from Opisthorchis viverrini. Parasitology 2004; 129: 455-64.
62. Thuwajit C, Thuwajit P, Uchida K, et al. Gene expression profiling defined pathways correlated with fibroblast cell proliferation induced by Opisthorchis viverrini excretory/secretory product. World J Gastroenterol 2006; 12: 3585-92.
63. Thuwajit P, Chawengrattanachot W, Thuwajit C, Sripa B, Paupairoj A, Chau-In S. Enhanced expression of mucin 6 glycoprotein in cholangiocarcinoma tissue from patients in Thailand as a prognostic marker for survival. J Gastroenterol Hepatol 2008; 23: 771-8.
64. Uenishi T, Hirohashi K, Kubo S, Yamamoto T, Yamazaki O, Kinoshita H. Clinicopathologi-cal factors predicting outcome after resection of mass-forming intrahepatic cholangio-carcinoma. Br J Surg 2001; 88: 969-74.
65. Uttaravichien T, Bhudhisawasdi V, Pairojkul C, Pugkhem A. Intrahepatic cholangiocarcinoma in Thailand. J Hepatobiliary Pancreat Surg 1999; 6:128-35.
66. Wang AG, Yoon SY, Oh JH, et al. Identification of intrahepatic cholangiocarcinoma related genes by comparison with normal liver tissues using expressed sequence tags. Biochem Biophys Res Commun 2006; 345:1022-32.